• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 180NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500318E
Device Problem Fluid/Blood Leak (1250)
Patient Problems Respiratory Arrest (4461); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/01/2022
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event Description
A user facility registered nurse (rn) reported that a dialyzer blood leak occurred at the end of a patient¿s hemodialysis (hd) treatment.In a follow up, the rn clarified that the blood leak occurred at the end of hd treatment while starting to rinse patient back.The treatment was immediately stopped and checked with blood strips which did test positive.The blood leak was described as being an internal blood leak.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm a few minutes earlier, but because the leak was not visually seen and blood test strips indicated negative at that time, the treatment was continued until the leak then became visible at the top of the dialyzer and into the hansen tubing.Fresenius bloodlines were used.The patient¿s estimated blood loss (ebl) was the amount in venous tubing (no estimated amount provided).There was no patient injury, adverse events or medical intervention required as a result of this event.There was no visible damage seen on the dialyzer prior to treatment.The treatment was considered completed at the time of the event.The device is available to be returned to the manufacturer for evaluation.
 
Event Description
A user facility registered nurse (rn) reported that a dialyzer blood leak occurred at the end of a patient¿s hemodialysis (hd) treatment.In a follow up, the rn clarified that the blood leak occurred at the end of hd treatment while starting to rinse patient back.The treatment was immediately stopped and checked with blood strips which did test positive.The blood leak was described as being an internal blood leak.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm a few minutes earlier, but because the leak was not visually seen and blood test strips indicated negative at that time, the treatment was continued until the leak then became visible at the top of the dialyzer and into the hansen tubing.Fresenius bloodlines were used.The patient¿s estimated blood loss (ebl) was the amount in venous tubing (no estimated amount provided).There was no patient injury, adverse events or medical intervention required as a result of this event.There was no visible damage seen on the dialyzer prior to treatment.The treatment was considered completed at the time of the event.The device is available to be returned to the manufacturer for evaluation.
 
Manufacturer Narrative
Additional information: d.9.,h.3.Plant investigation: the complaint device was not returned to the manufacturer for physical evaluation.The third party carrier's website was reviewed and it was verified that the fmcna-provided shipping materials were sent to the customer and were subsequently received.In the event a sample is returned for evaluation, the complaint file will be updated.The report could not be confirmed as a definitive conclusion regarding the complaint incident cannot be reached based on the information provided.A review of the production record was performed.There was no indication of product non-acceptance or deviation in the manufacturing process related to the complaint event.This includes non-conformances, rework, labeling, process controls, and any other occurrence in production that was potentially related to the complaint.The reported lot number passed pyrogen testing, was within sterilization dosage parameters and passed all release criteria.Continuous improvement is of the utmost importance to fresenius medical care as we strive to provide dialysis products of the highest quality to our patients.Reports of leaking product are investigated both individually as complaints, as well as via the nc/capa program, in order to assess and improve our products and processes.Capas for vision systems and blood leak reduction are recent examples of leak related investigations directed at an overall reduction in dialyzer leaks.
 
Event Description
A user facility registered nurse (rn) reported that a dialyzer blood leak occurred at the end of a patient¿s hemodialysis (hd) treatment.In a follow up, the rn clarified that the blood leak occurred at the end of hd treatment while starting to rinse patient back.The treatment was immediately stopped and checked with blood strips which did test positive.The blood leak was described as being an internal blood leak.The machine, a fresenius 2008t machine, alarmed appropriately with a blood leak alarm a few minutes earlier, but because the leak was not visually seen and blood test strips indicated negative at that time, the treatment was continued until the leak then became visible at the top of the dialyzer and into the hansen tubing.Fresenius bloodlines were used.The patient¿s estimated blood loss (ebl) was the amount in venous tubing (no estimated amount provided).There was no patient injury, adverse events or medical intervention required as a result of this event.There was no visible damage seen on the dialyzer prior to treatment.The treatment was considered completed at the time of the event.The device is available to be returned to the manufacturer for evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 180NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key15185520
MDR Text Key301154942
Report Number0001713747-2022-00302
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100156
UDI-Public00840861100156
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K162488
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Nurse
Type of Report Initial,Followup,Followup
Report Date 09/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number0500318E
Device Catalogue Number0500318E
Device Lot Number22EU03020
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Device AgeMO
Initial Date Manufacturer Received 08/01/2022
Initial Date FDA Received08/08/2022
Supplement Dates Manufacturer Received08/24/2022
09/06/2022
Supplement Dates FDA Received08/29/2022
09/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/31/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age36 YR
Patient SexMale
Patient Weight100 KG
-
-